Professor David Cherney
University of Toronto, Toronto (Canada)
Mediators of the effect of ertugliflozin on a composite kidney outcome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: analyses from VERTIS CV
Event: ESC Congress 2021 - The Digital Experience
Topic: Renal Failure and Cardiovascular Disease
Session: Cardiovascular Disease in Special Populations ePosters
ESC 365 is supported by
